Symfi Lo is a prescription medication used to treat HIV-1 infection in adults and pediatric patients weighing at least 35 kg. It is a fixed-dose combination tablet containing three different antiretroviral drugs: efavirenz, lamivudine, and tenofovir disoproxil fumarate. These drugs work together to help control the HIV virus and improve the immune system’s ability to fight off infections.
Efavirenz is a non-nucleoside reverse transcriptase inhibitor that helps prevent the virus from multiplying in the body. Lamivudine and tenofovir disoproxil fumarate are nucleoside reverse transcriptase inhibitors that also work to inhibit the virus’s ability to replicate. By combining these three drugs into one convenient tablet, Symfi Lo simplifies the treatment regimen for patients with HIV-1 infection.
It is important to take Symfi Lo exactly as prescribed by your healthcare provider. Missing doses or not taking the medication as directed can lead to the virus becoming resistant to the drugs and may reduce the effectiveness of treatment. Common side effects of Symfi Lo may include dizziness, trouble sleeping, nausea, and rash. It is important to discuss any side effects or concerns with your healthcare provider.
Before starting Symfi Lo, it is important to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you may have. Some medications or medical conditions may interact with Symfi Lo or require dosage adjustments.
Overall, Symfi Lo is an effective and convenient treatment option for individuals living with HIV-1 infection. By following your healthcare provider’s instructions and staying informed about your treatment, you can help manage your condition and improve your quality of life.